Evonik appoints Yann d’Hervé as new head of Health Care business line
Yann d’Hervé, previously Head of the Care Solutions business line in Evonik’s Nutrition & Care division, will lead the Health Care business line as of July 1. ... MORE
Find the latest news from our company.
Yann d’Hervé, previously Head of the Care Solutions business line in Evonik’s Nutrition & Care division, will lead the Health Care business line as of July 1. ... MORE
Key innovations include the new concept of AvailOm® & Boswellia for joint health, the latest study results on IN VIVO BIOTICS™ and the expansion of the Healthberry® portfolio to the U.S. market. ... MORE
The company received the award for its Cell Culture Solutions portfolio in the category Best New Bioprocessing Supplier Award: Upstream Processing. ... MORE
EUDRAGIT® polymers have been used as coatings to create more effective drugs for 70 years. Over the decades, the portfolio of methacrylate polymers has established itself as the industry standard. ... MORE
Evonik and the University of Mainz have signed a license agreement to commercialize randomized polyethylene glycols (rPEGs), a new class of PEGs. ... MORE
Evonik’s non-animal-derived squalene PhytoSquene® is now available produced under GMP. PhytoSquene® is the first GMP amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. ... MORE